Re:Y Combinator ups the ante with bio startups for 2015
by Gatsky on Monday March 23, 2015 @08:30PM
(#9254212)
23 and me is an example of the least ambitious thing you could do with genomics.
Honestly, I think you are being needlessly negative. There is a lack of life sciences research funding and an oversupply of life science researchers. What's the disadvantage of more biotech startups? Public-private collaborations with small nimble startups sounds like a dream come true, compared to years waiting for the wheels to turn in collaborations with big pharma.
[ Parent
| on HN ]
There are no comments on this comment yet.